Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

In a groundbreaking achievement, an Iranian knowledge-based company has developed a new method for synthesizing Technetium (99mTc) tilmanocept, a crucial radiopharmaceutical diagnostic imaging agent. This innovative product is designed to aid in the identification of lymph nodes that may be draining from tumors, significantly impacting cancer treatment strategies.

Since 2013, the United States has stood as the sole manufacturer of this vital radiopharmaceutical agent, as reported by IRNA. The lymphatic system plays a critical role in cancer metastasis, making accurate detection of lymph node involvement essential for effective surgical intervention, particularly in patients diagnosed with breast, lung, and genital tract cancers.

Without timely identification of affected lymph nodes, surgeons may resort to removing large sections of the lymphatic system. This invasive procedure can lead to numerous side effects and severely compromise a patient’s immune system and blood circulation. The newly developed radiodiagnostic agent will assist healthcare professionals in pinpointing lymph nodes for removal, thus preserving healthy lymphatic tissue and reducing unnecessary surgeries and complications.

Thanks to this remarkable advancement, approximately 90 percent of cancer patients in Iran will have access to a more affordable and accurate diagnostic and treatment method. The drug has successfully progressed through preclinical phases and is now in the clinical trial stage.

Cancer remains one of the most pressing global health challenges, impacting millions of individuals each year. According to the Iranian Health Ministry, cancers are the leading cause of premature mortality in the country, contributing to over 55,000 deaths annually. Of these, around 34,000 deaths occur among those under 70 years, and 11,000 among those under 50 years of age, resulting from various cancer types.

The latest national cancer census indicates a concerning trend, with new cancer cases in Iran projected to rise to 160,000 by the Iranian calendar year 1404 (March 2025-March 2026), representing a 43 percent increase. The ten most common cancers in Iran include:

  • Breast Cancer
  • Prostate Cancer
  • Colon Cancer
  • Stomach Cancer
  • Lung Cancer
  • Bladder Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Brain Cancer
  • Spinal Cancer

For Iranian women, the most prevalent cancers consist of:

  • Breast Cancer
  • Colon Cancer
  • Thyroid Cancer
  • Stomach Cancer
  • Uterine Cancer
  • Leukemia
  • Ovarian Cancer
  • Brain Cancer
  • Spinal Cancer
  • Lung Cancer
  • Esophageal Cancer

Currently, around 250,000 Iranians are living with cancer. It is noteworthy that nearly half of all cancers can be treated effectively, while the remainder can often be prevented.

Recent Achievements in Cancer Research

On January 20, 2024, the Iran University of Medical Sciences (IUMS) announced the development of an artificial intelligence (AI)-based system capable of detecting breast cancer with a remarkable 94 percent accuracy, as reported by IRNA. Breast cancer is the second leading cause of mortality among women in Iran, with approximately 30 percent of patients succumbing to the disease each year, aligning closely with the global average.

Early detection is crucial as it significantly enhances the chances of successful treatment and survival. In addition, an Iranian knowledge-based company has expressed readiness to fulfill the demand for the human papillomavirus (HPV) vaccine across regional countries and North Africa. This vaccine is essential as HPV is a known cause of cervical cancer in women.

The HPV vaccine has been produced at a substantially reduced cost, being 75 percent cheaper than foreign alternatives. Manufacturing the HPV vaccine involves one of the most intricate technologies globally, yet Iran has successfully developed this vaccine domestically. Following rigorous safety and efficacy trials, the vaccine received approval from the Food and Drug Organization in 2020.

In a notable achievement for cancer treatment, an Iranian knowledge-based company successfully produced ibrutinib, a medication used to treat various blood cancers, positioning Iran as the third country in the world capable of producing this advanced treatment. Now, Iran joins India and China as the only nations with the expertise to manufacture ibrutinib and its necessary raw materials, according to IRNA.

These advancements in cancer treatment and diagnosis signify a pivotal moment for healthcare in Iran, promising better outcomes for patients and a brighter future in the fight against cancer.

Similar Posts

  • Iran’s Tabatabaei Triumphs at Bavarian International Open: A Stellar Victory!

    On November 10, 2025, a major announcement reshaped the sports landscape, prompting significant reactions from teams, athletes, and fans. Key highlights include the introduction of new policies aimed at enhancing competitive balance, which will require teams to adjust strategies and navigate financial changes. The announcement also suggests an uptick in player transfers during the next window. Fans expressed both excitement and concern on social media, speculating on how these changes will affect their teams. Experts believe this moment could lead to increased parity in the league, making the upcoming season particularly intriguing as teams adapt to the new environment.

  • This article will be expanded with more detailed information shortly. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information…

  • Iran Unveils Vibrant Cultural Treasures at Shahab International Exhibition in Baghdad

    Iran is preparing for a major presence at the 4th Shahab International Exhibition for Children and Adolescents in Baghdad from November 19 to 29, focusing on promoting cultural products in animation and toys. Organizers aim to expand into international markets, particularly Iraq, which offers a youthful consumer base. The exhibition will showcase 50 producers and 300 products, including video games and startups. Iranian officials stress the need for export growth, with plans for a permanent office to facilitate trade. The event is expected to enhance Iran’s cultural production sector and strengthen ties with Iraqi traders and officials.

  • Iran and Qatar Boost Customs Cooperation: Strengthening Trade Relations for a Brighter Future

    A recent meeting in Tehran between Qatar’s General Authority of Customs Chairman Ahmed bin Abdullah Al Jamal and Foroud Asgari, head of Iran’s Customs Administration, highlighted the strengthening bilateral relations between the two nations. The discussions focused on enhancing cooperation in customs operations, with Al Jamal praising Iran’s advancements in electronification. Both officials emphasized the importance of ongoing dialogue, periodic joint visits, and regular high-level meetings to improve trade efficiency. Their collaboration aims to address immediate operational needs and foster long-term economic partnerships, reflecting a broader trend of regional cooperation amidst global economic challenges.

  • Iran Set to Showcase Futsal Skills at Thailand’s Exciting International Tournament!

    Iran’s national futsal team is preparing for the prestigious 2025 NSDF Futsal Championships in Nonthaburi, Thailand, an invite-only tournament featuring elite Asian teams. Confirmed by Ehsan Osouli of the Iranian football federation, this participation is a significant milestone for Team Melli, led by coach Vahid Shamsaei. The team is rigorously training to enhance skills, tactics, and fitness in anticipation of tough competition. Additionally, they will compete in a tournament in Brazil against strong contenders like France and the host nation. This growing prominence of futsal in Iran aims to inspire future players and elevate the nation’s standing in the sport.

  • FM Araghchi and IAEA Chief Connect Amid Ongoing Iran-US Negotiations

    Indirect talks between Iran and the U.S. are gaining momentum with assistance from the International Atomic Energy Agency (IAEA). Recent communications between Iranian officials and IAEA Director General Rafael Grossi emphasize a commitment to diplomacy regarding nuclear negotiations. The Iranian Foreign Ministry stated that Grossi offered support for advancing discussions, which both sides have described as positive and constructive. Grossi praised Iran’s diplomatic approach, while Iranian Deputy Foreign Minister Abbas Araghchi traveled to China, indicating ongoing international engagement. The IAEA’s role is crucial in fostering trust and transparency, potentially leading to a diplomatic resolution with significant implications for regional stability.